End-tidal carbon dioxide in the diagnosis of acute pulmonary embolism in hospitalized adult patients
Abstract
Pulmonary embolism (PE) causes 100,000 deaths and contributes to over 4 billion dollars of annual healthcare costs. Acute PE is a diagnostic challenge as symptoms vary widely and are often nonspecific. Definitive diagnosis requires costly confirmatory testing with computed tomography pulmonary angiogram (CTPA). CTPA risks include allergic reactions, contrast-induced nephropathy and radiation exposure. The purpose of this study is two-fold: 1) to examine the accuracy, financial impact, and harm avoidance of adding EtCO[2] to the PE diagnostic process and 2) to evaluate clinician adherence to national guidelines (BPA) for PE diagnosis. A single center prospective, descriptive, correlational design comparing EtCO[2] values to CTPA results. Medical records were reviewed to determine BPA adherence. A total of 111 patients had definitive CT results. Mean ([plus or minus]SD) EtCO[2] was higher for PE+ (28[plus or minus]7.8) versus PE- (33[plus or minus] 8.1) patients (p =.01). For PE exclusion, an EtCO[2] cutoff value of [greater than or equal to]42mmHg yielded a sensitivity of 100%, specificity of 12.2% and a negative predictive value of 100% and could safely eliminate 11 patients (9.9%) from receiving CTPA. For every 6 patients assessed with EtCO[2], one can be saved from CTPA. Overall BPA adherence was 0%. Partial adherence was observed with clinician recorded clinical decisions rules in 3.6% (4/111) and D-dimer was obtained in 10.2% (9/88). EtCO[2] cutoff value of [greater than or equal to]42mmHg could decrease CTPA scans use in [about]10% of adult inpatients suspected of PE eliminating exposure to CTPA risks. Lack of clinical decision support may contribute to low BPA compliance.
Degree
Ph. D.
Thesis Department
Rights
OpenAccess.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.